Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in adult recipients of kidney transplantation: a real-world data study
Objectives: To evaluate the efficacy and safety of low-dose trimethoprim (TMP)-sulfamethoxazole (SMX) (TMP-SMX) as the primary prophylaxis for Pneumocystis jirovecii pneumonia (PJP) in adult recipients of kidney transplantation. Methods: Three kinds of prescriptions in kidney recipients were documen...
Main Authors: | Ruo-Yang Chen, Da-Wei Li, Jie-Ying Wang, Shao-Yong Zhuang, Hao-Yu Wu, Jia-Jin Wu, Jun-Wen Qu, Nan Sun, Chen Zhong, Cheng Zhu, Ming Zhang, Yue-Tian Yu, Xiao-Dong Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971222005434 |
Similar Items
-
Time to trimethoprim/sulfamethoxazole initiation among patients with rheumatic disease complicated by Pneumocystis jirovecii pneumonia: impact on 90-day mortality
by: Siyang Song, et al.
Published: (2022-12-01) -
A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital
by: Hao Li, et al.
Published: (2024-01-01) -
Analysis on Prophylaxis of Pneumocystis Carini Pneumonia by Trimethoprim-Sulfamethoxazole in Patients with Autoimmune Diseases
by: QUE Yongtu, et al.
Published: (2023-01-01) -
Clinical descriptive analysis of severe Pneumocystis jirovecii pneumonia in renal transplantation recipients
by: Dan Xie, et al.
Published: (2021-01-01) -
Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis
by: Albert Dunbar, et al.
Published: (2020-05-01)